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Abstract	1	
Gastric	 colonization	 with	 Helicobacter	 pylori	 induces	 diverse	 human	 pathological	2	
conditions,	 including	 superficial	 gastritis,	 peptic	 ulcer	 disease,	 mucosa-associated	3	
lymphoid	tissue	(MALT)	lymphoma,	and	gastric	adenocarcinoma	and	its	precursors.	4	
The	 treatment	 of	 these	 conditions	 often	 relies	 on	 the	 eradication	of	H.	 pylori,	 an	5	
intervention	that	is	increasingly	difficult	to	achieve	and	that	does	not	prevent	disease	6	
progression	in	some	contexts.	There	is,	therefore,	a	pressing	need	to	develop	new	7	
experimental	models	of	H.	pylori-associated	gastric	pathology	to	support	novel	drug	8	
development	in	this	field.	Here,	we	review	the	current	status	of	in-vivo	and	ex-vivo	9	
models	 of	 gastric	 H.	 pylori	 colonization,	 and	 of	 Helicobacter-induced	 gastric	10	
pathology,	focusing	on		models	of	gastric	pathology	induced	by	H.	pylori,	H.	felis	and	11	
H.	suis	in	rodents	and	large	animals.	We	also	discuss	the	more	recent	development	12	
of	gastric	organoid	cultures	from	murine	and	human	gastric	tissue,	as	well	as	from	13	
human	 pluripotent	 stem	 cells,	 and	 the	 outcomes	 of	 H.	 pylori	 infection	 in	 these	14	
systems.	15	
Keywords	16	
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gastroid.	 	18	
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Introduction	1	
Helicobacter	pylori	 is	a	bacterium	that	grows	in	close	association	with	the	lining	of	2	
the	 	 stomach	 and	 is	 associated	 with	 various	 human	 gastric	 diseases;	 it	 causes	3	
significant	morbidity	and	mortality	worldwide.	Globally,	there	are	wide	variations	in	4	
the	reported	prevalence	of	H.	pylori	(Figure	1),	with	particularly	high	levels	observed	5	
in	South	America,	Sub-Saharan	Africa	and	the	Middle	East		(Asfeldt	et	al,	2008;	Ben	6	
Mansour	et	al,	2016;	Laszewicz	et	al,	2014;	Luzza	et	al,	2014;	McDonald	et	al,	2015;	7	
Peleteiro	et	al,	2014;	Saltanova,	2001;	Sanchez	Ceballos	et	al,	2007;	van	Blankenstein	8	
et	al,	2013).		9	
Many	publications	have	promoted	the	concept	of	“the	African	Enigma”	(Holcombe,	10	
1992),	owing	to	the	reporting	of	fewer	cases	of	peptic	ulceration	than	expected	in	11	
this	 continent.	However,	 recent	 studies	 suggest	 that	 gastric	 pathology	 is	 endemic	12	
where	H.	 pylori	 is	 endemic	 (Agha	 and	Graham,	 2005).	 They	 also	 suggest	 that	 the	13	
geographical	distribution	of	gastric	disease	and	its	predominant	form		relates	more	14	
to	 other	 co-factors,	 such	 as	 H.	 pylori	 virulence	 properties,	 food	 preservation	15	
methods,	diet,	and	host	genetics	(Graham	et	al,	2009;	Kodaman	et	al,	2014).		16	
One	 of	 the	 principal	 confounders	 of	 studies	 examining	 the	 impact	 of	 H.	 pylori	17	
infection	 on	 gastric	 health	 in	 diverse	 populations	 is	 the	 inequality	 of	 access	 to	18	
healthcare	systems	globally.	Diagnosing	Helicobacter	infection	relies	on	one	of	four	19	
tests:	endoscopy	with	biopsy;	13Carbon-hydrogen	breath	test;	fecal	antigen	testing;	20	
or	 serological	 detection	 of	 an	 anti-H.	 pylori	 antibody.	 These	 tests	 are	 relatively	21	
expensive	and	their	availability	is	limited,	particularly	in	developing	countries	where	22	
the	highest	H.	pylori	prevalence	has	been	reported.	23	
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For	many	H.	pylori	associated	conditions,	the	most	effective	clinical	intervention	is	to	1	
eradicate	 the	 infection	 using	 a	 combination	 of	 acid-suppressing	 medication	 and	2	
antibiotics.	 However,	 this	 strategy	 is	 becoming	 increasingly	 difficult	 to	 sustain	3	
because	of	the	emergence	of	antibiotic-resistant	H.	pylori	strains.	Moreover,	in	some	4	
clinical	 circumstances,	 H.	 pylori	 eradication	 is	 ineffective	 at	 preventing	 disease	5	
progression.	 There	 is,	 therefore,	 an	 unmet	 need	 to	 develop	 new	 drugs,	 both	 to	6	
eradicate	H.	pylori	more	effectively	and	to	offer	alternative	strategies	where	infection	7	
eradication	does	not	prevent	the	progression	of	gastric	pathology.		8	
To	achieve	this,	we	need	to	improve	our	understanding	of	the	molecular	events	that	9	
lead	to	H.	pylori	induced	gastric	pathology,	and	this	requires	experimental	models.	10	
Here,	we	review	the	currently	available	in-vivo	and	ex-vivo	models	of	Helicobacter-11	
induced	pathology,	and	describe	the	spectrum	of	pathology	induced	by	H.	pylori,	H.	12	
felis	and	H.	suis	infection.	The	in-vivo	models	discussed	here	span	rodent	and	larger	13	
animal	models,	including	cat,	dog,	pig	and	non-human	primate	models,	whilst	the	ex-14	
vivo	models	 derive	 from	mouse	 and	 human	 gastric	mucosa	 and	 from	pluripotent	15	
stem	 cells.	 It	 is	 particularly	 timely	 to	 review	 these	ex-vivo	models	 because	of	 the	16	
recent	 development	 of	 long-lived	 ex-vivo	 cultures	 of	 untransformed	 gastric	17	
epithelium	 (Barker	 et	 al,	 2010).	 These	 offer	 an	 important	 adjunct	 to	 the	 more	18	
established	animal	models	of	gastric	carcinogenesis,	and	make	 it	 likely	that	 future	19	
mechanistic	studies	of	gastric	disease	will	incorporate	elements	of	both	in-vivo	and	20	
ex-vivo	experimentation.	21	
Helicobacter	pylori:	an	overview	22	
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The	gastric	microenvironment	(Figure	2)	is	hostile	to	commensal	bacteria	due	to	the	1	
presence	of	high	concentrations	of	gastric	acid	and	digestive	enzymes	and	because	2	
of	 its	 low	partial	 oxygen	pressure.	H.	 pylori	 is	 a	Gram-negative,	 spiral	 rod-shaped	3	
bacterium	that	has	evolved	to	survive	in	this	environment.	Its	adaptations	to	these	4	
conditions	include	an	ability	to	tolerate	a	microaerophilic	environment	(see	Glossary,	5	
Box	 1),	 the	 expression	 of	 a	 urease	 enzyme	 that	 modulates	 the	 bacterial	6	
microenvironment	by	raising	pH,	and	flagellae	that	provide	motility,	allowing	H.	pylori	7	
to	 access	 the	 deep	 mucus	 layer	 of	 the	 stomach	 wall,	 thereby	 utilizing	 the	 host	8	
mucosal	defenses	to	develop	a	survivable	niche.		9	
The	transmission	of	H.	pylori	infection	is	considered	to	occur	through	an	oro-oral	or	10	
feco-oral	route.	Data	from	families	indicates	that	vertical	transmission	from	parent	11	
to	child	is	a	common	transmission	route.	A	recent	phylogenetic	study	in	an	Iranian	12	
population	examined	transmission	by	DNA	fingerprinting	of	H.	pylori	16S	ribosomal	13	
sub-unit	DNA	obtained	from	fecal	samples.	This	assay	detected	H	.pylori	DNA	in	26	of	14	
30	cases,	and	demonstrated	the		vertical	transmission	of	H.	pylori	in	46.1%	of	families,	15	
with	38.4%	of	cases	being	colonized	with	an	H.	pylori	strain	phylogenetically	identical	16	
to	their	mother’s	strain,	and	7.7%	with	a	strain	identical	to	their	father’s	(Mamishi	et	17	
al,	2016).	These	findings	agree	with	similar	studies	performed	in	other	populations	18	
(Konno	et	al,	2005;	Konno	et	al,	2008;	McMillan	et	al,	2011;	Roma-Giannikou	et	al,	19	
2003),	and	are	supported	by	animal	studies.		For	example,	one	study	reported	that	in	20	
an	H.	pylori	infected	cat	colony,	kittens	were	passively	colonized	by	H.	pylori	over	the	21	
first	14	weeks	of	life	(Straubinger	et	al,	2003).	22	
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The	global	prevalence	of	H.	pylori	infection	in	humans	is	estimated	to	be	50%.	The	1	
association	 of	 H.	 pylori	 with	 humans	 is	 longstanding,	 with	 phylogenetic	 studies	2	
suggesting	 that	 H.	 pylori	 strains	 have	 co-evolved	 with	 human	 populations	 since	3	
before	 the	migration	of	 early	 humans	 from	Africa	 58,000	 years	 ago	 (Falush	 et	 al,	4	
2003;	Linz	et	al,	2007).		Below,	we	discuss	the	consequences	of	H.	pylori	infection	for	5	
human	health,	to	establish	the	types	of	pathology	that	need	to	be	modelled	in	the	6	
laboratory.		7	
	8	
Helicobacter	induced	gastric	pathology	in	humans	9	
Chronic	infection	with	H.	pylori	is	strongly	associated	with	gastric	pathology,	including	10	
chronic	 active	 gastritis	 (see	 Glossary,	 Box	 1),	 peptic	 ulcer	 disease,	 gastric	11	
adenocarcinoma,	 and	 gastric	 extranodal	 marginal	 zone	 lymphoma	 of	 mucosa-12	
associated	 lymphoid	 tissue	 type	 (MALT	 lymphoma).	Of	 these	outcomes,	 the	most	13	
significant	 in	 terms	 of	mortality	 is	 gastric	 adenocarcinoma.	 Recent	meta-analyses	14	
suggest	that	the	relative	risk	of	developing	gastric	cancer	is	2	to	3	times	higher	for	15	
people	 infected	 with	 H.	 pylori	 than	 for	 those	 without	 infection	 (Danesh,	 1999;	16	
Helicobacter	 and	 Cancer	 Collaborative,	 2001).	 Understanding	 these	 different	17	
pathological	conditions	 is	 important	for	understanding	how	faithfully	the	available	18	
models	recapitulate	the	clinical	features	of	H.	pylori	pathology.	19	
Superficial	Gastritis	20	
The	commonest	outcome	of	H.	pylori	infection	is	gastritis.	Acute	gastritis	has	rarely	21	
been	described	in	humans,	but	has	been	reported	in	the	context	of	experimentalists	22	
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being	exposed	to	H.	pylori	either	accidentally	(Sobala	et	al,	1991)	or	in	a	deliberate	1	
attempt	 to	 induce	 gastric	 pathology	 (Marshall	 et	 al,	 1985;	Morris	 and	Nicholson,	2	
1987;	Morris	et	al,	1991).	In	these	cases,	the	infected	individuals	reported	symptoms	3	
and	underwent	endoscopic	assessment	with	biopsy	of	the	inflamed	gastric	mucosa.	4	
The	 early	 stages	 of	 disease	 are	marked	 by	 the	 presence	 of	 a	 polymorphonuclear	5	
leukocyte	 infiltrate	 (see	 Glossary,	 Box	 1)	 in	 the	 gastric	 mucosa	 and	 a	 transient	6	
reduction	in	gastric	acid	output.		7	
In	the	cases	of	Marshall	et	al	and	Morris	and	Nicholson,	H.	pylori	eradication	therapy	8	
was	prescribed.	This	was	effective	in	eradicating	H.	pylori	from	the	gastric	mucosa,	9	
and	 led	 to	 the	 complete	 resolution	 of	 symptoms	 and	 of	 gastric	 histological	10	
abnormalities.	 In	 the	 case	 of	 Sobala	 et	 al,	 symptoms	 and	 signs	 resolved	11	
spontaneously,	 and	 repeat	 endoscopy	 demonstrated	 low	 levels	 of	 Helicobacter	12	
colonizing	the	gastric	antrum,	together	with	an	increase	in	lymphocytes	within	the	13	
gastric	 mucosa.	 These	 histological	 changes	 correlated	 with	 IgM	 and	 IgG	14	
seroconversion	 for	 H.	 pylori,	 which	 are	 typical	 for	 chronic,	 superficial	 H.	 pylori	15	
gastritis.	 This	 is	 the	most	prevalent	H.	pylori	 induced	gastric	pathology	worldwide	16	
(Campbell	et	al,	2001;	Filipe	et	al,	1995;	Potet	et	al,	1993).		17	
Peptic	ulcer	disease		18	
Individuals	colonized	with	H.	pylori	have	a	6.8-fold	(95%	confidence	interval	(CI)	2.9-19	
16.1)	higher	risk	of	developing	peptic	ulcer	disease	(PUD)	than	those	not	exposed	to	20	
this	 infection	 (Li	 et	 al,	 2010).	 In	 line	with	 this,	 the	 reduced	 incidence	 of	H.	 pylori	21	
infection	worldwide	has	coincided	with	a	reduction	in	PUD	(Groenen	et	al,	2009).		In	22	
contrast	to	the	1980s,	when	the	association	of	H.	pylori	and	PUD	was	first	established	23	
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(Graham,	 1989),	 individuals	 presenting	with	 this	 disease	 are	 now	 less	 likely	 to	 be	1	
colonized	with	H.	pylori;	more	often,	their	condition	is	linked	to	non-steroidal	anti-2	
inflammatory	drug	use	or	to	low	dose	aspirin	(Musumba	et	al,	2012;	Sung	et	al,	2009).	3	
H.	 pylori	 induced	 peptic	 ulceration	 occurs	 in	 the	 context	 of	 pre-existing	 chronic	4	
superficial	gastritis,	but	 is	associated	with	 increased	gastric	acid	secretion	and	a	T	5	
helper	 1	 (Th1)	 polarized	 immune	 response,	 compared	 to	 individuals	with	 isolated	6	
superficial	gastritis	(D'Elios	et	al,	1997;	Shimada	et	al,	2002).	7	
Frequently,	individuals	with	PUD	exhibit	antral	predominant	gastritis,	which	leads	to	8	
enhanced	gastrin	secretion	(see	Glossary,	Box	1).	In	turn,	this	stimulates	the	parietal	9	
cells	of	the	gastric	corpus	(Figure	2)	to	secrete	more	acid	(McColl	et	al,	1997),	leading	10	
to	mucosal	ulceration.	Eradication	of	H.	pylori	 	 is	 reportedly	sufficient	 to	suppress	11	
excess	gastrin	secretion	(McColl	et	al,	1991),	which	is	an	important	component	of	the	12	
healing	process	of	H.	pylori	associated	peptic	ulcers.	13	
Gastric	adenocarcinoma	and	its	precursor	lesions	14	
In	2012,	gastric	cancer	was	the	fifth	commonest	malignancy	worldwide,	and	the	third	15	
commonest	 cause	 of	 cancer	 related	 death,	 with	 over	 720,000	 deaths	 worldwide	16	
caused	by	the	disease	(Ferlay	J,	2013).	H.	pylori	colonization	is	the	single	biggest	risk	17	
factor	for	gastric	carcinogenesis	and	is	a	risk	factor	in	at	least	80%	of	cases	of	gastric	18	
cancer	(Graham,	2015).	However,	as	only	a	very	small	percentage	of	people	infected	19	
with	H.	pylori	go	on	to	develop	gastric	cancer,	understanding	why	those	individuals	20	
do	so	is	a	key	aim	of	future	studies	in	this	field.	21	
Other	risk	factors	linked	to	gastric	cancer	(Figure	3)	fall	 into	two	main	groups.	The	22	
first	consists	of	potentially	modifiable	exogenous	risk	factors,	such	as	dietary	salt	and	23	
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nitrosamine	intake	(Jakszyn	et	al,	2006;	M	et	al,	2007;	Mendez	et	al,	2007;	Wang	et	1	
al,	 2009),	 H.	 pylori	 virulence	 factors	 (Yamaoka,	 2010),	 non-Helicobacter	 gastric	2	
microbiota	(Dicksved	et	al,	2009;	Lofgren	et	al,	2011)	and	smoking	status	(La	et	al,	3	
2009).	The	second	group	consists	of	unalterable	host	genetic,	or	intrinsic,	risk	factors.	4	
Amongst	 these	 genetic	 factors	 are	 polymorphisms	 at	 loci	 encoding	 cytokines	 and	5	
their	 receptors	 (Persson	 et	al,	 2011),	 stromal	 remodeling	proteins,	 such	as	matrix	6	
metalloproteinases	(Tang	et	al,	2008),	and	prostate	stem	cell	antigen	(PSCA),	which	7	
in	the	context	of	gastric	pathology,	acts	as	a	tumor	suppressor	gene	(Garcia-Gonzalez	8	
et	al,	2015;	Ichikawa	et	al,	2015;	Mou	et	al,	2015).	9	
The	 development	 of	 gastric	 cancer	 occurs	 through	 a	 stereotypical	 pathological	10	
pathway	(Figure	3,	and	Glossary,	Box	1),	which	was	first	proposed	well	before	the	11	
identification	of	H.	pylori	 (Correa	et	al,	1975).	Over	the	course	of	several	decades,	12	
some	 individuals	 with	 chronic	 superficial	 gastritis	 develop	 gastric	 atrophy,	13	
characterized	by	the	patchy	loss	of	parietal	cells	in	the	gastric	corpus	mucosa.	This	14	
decreases	 gastric	 acid	 secretion,	 leading	 to	 higher	 intraluminal	 pH,	 decreased	15	
somatostatin	secretion,	and	consequent	gastrin	secretion.	In	addition	to	stimulating	16	
acid	secretion	from	parietal	cells,	gastrin	also	enhances	proliferation	 in	the	gastric	17	
epithelial	 stem	 cell	 zone	 (Burkitt	 et	 al,	 2009),	 leading	 to	 increased	 epithelial	 cell	18	
turnover.	19	
A	 proportion	 of	 people	 with	 established	 gastric	 atrophy	 develop	 intestinal	 type	20	
metaplasia	 (see	 Glossary,	 Box	 1)	 of	 the	 gastric	mucosa	 over	 time,	 where	 oxyntic	21	
glands	 (see	 Glossary,	 Box	 1)	 are	 replaced	 by	 CDX2	 (caudal	 type	 homeobox	 2)-22	
expressing	glandular	units,	which	are	morphologically	similar	to	the	intestinal	crypt.	23	
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Intestinal	metaplasia	in	the	stomach	is	linked	to	gastric	dysplasia	(see	Glossary,	Box	1	
1);	 up	 to	 20%	 of	 affected	 individuals	 with	 intestinal	 metaplasia	 have	 concurrent	2	
dysplasia	(den	Hoed	et	al,	2011).	Gastric	epithelial	dysplasia	is	associated	with	an	at	3	
least	10-fold	increased	risk	of	developing	gastric	cancer	(You	et	al,	1999),	but	it	has	4	
been	difficult	to	represent	this	risk	accurately	from	population-based	studies.		5	
Several	studies	have	assessed	the	strategy	of	testing	for,	and	eradicating,	H.	pylori	in	6	
populations	at	a	high	risk	of	developing	gastric	cancer.	Unfortunately,	a	recent	well-7	
designed	meta-analysis	confirmed	a	relatively	poor	outcome	for	 this	strategy.	The	8	
eradication	of	H.	pylori	in	this	study	reduced	the	risk	of	developing	gastric	cancer	by	9	
~1/3	(OR	0.66	[95%	CI	0.46	–	0.95])	(Ford	et	al,	2014).	However,	when	patients	with	10	
pre-existing	 pre-neoplastic	 gastric	 pathology	 (defined	 as	 the	 presence	 of	 gastric	11	
atrophy,	intestinal	metaplasia,	or	dysplasia)	were	considered,	there	was	no	evidence	12	
that	eradication	of	H.	pylori	decreased	the	risk	of	gastric	cancer	(OR	0.86	[95%	CI	0.47	13	
–	 1.59]).	 For	 this	 highest	 risk	 group	 of	 patients,	 therefore,	 there	 are	 currently	 no	14	
effective	therapeutic	strategies.	15	
MALT	lymphoma		16	
Gastric	extranodal	marginal	zone	lymphomas	of	mucosa-associated	lymphoid	tissue	17	
(MALT	 lymphomas)	 	 are	 B-cell	 lymphomas	 that	 develop	 within	 the	 mucosa-18	
associated	 lymphoid	 tissue	 of	 the	 stomach.	 The	 incidence	 rate	 of	 gastric	 MALT	19	
lymphoma	in	the	USA	was	estimated	to	be	3.8	per	in	1,000,000	individuals	between	20	
2001	and	2009,	making	it	a	rare	outcome	of	H.	pylori	infection	(Khalil	et	al,	2014).	In	21	
the	only	published	systematic	review	of	this	condition,	79%	of	1844	reported	cases	22	
	11	
	
of	MALT	 lymphoma	were	 associated	with	H.	 pylori	 infection	 (Asenjo	 and	Gisbert,	1	
2007;	Gisbert	and	Calvet,	2011).		2	
As	with	other	hematological	malignancies,	 characteristic	 cytogenetic	profiles	have	3	
been	described	 for	MALT	 lymphoma.	Amongst	 the	most	well	 characterized	 is	 the	4	
formation	of	 the	MALT1-API2	 fusion	oncogene	by	 the	 t	 (11:18)	 translocation.	This	5	
results	in	the	expression	of	API2	(encoding	the	cellular	inhibitor	of	apoptosis	2)	under	6	
the	control	of	the	MALT1	promoter	(Rosebeck	et	al,	2011).	MALT1	encodes	mucosa-7	
associated	lymphoid	tissue	lymphoma	translocation	protein	1,	which	is	essential	for	8	
the	activation	and	proliferation	of	T	and	B	lymphocytes,	and	also	plays	a	fundamental	9	
role	in	NF-κB		(Nuclear	Factor-κB)	activation.	One	of	the	downstream	effects	of	this	10	
fusion	protein	is	enhanced	cleavage	of	NIK	(NF-κB-inducing	kinase),	which	is	a	critical	11	
regulator	of	alternative	pathway	NF-κB	signaling	(Merga	et	al,	2016).	12	
Human	infections	with	non-Helicobacter	pylori	Helicobacter	species	13	
Whilst	 infection	of	 the	gastric	mucosa	with	H.	pylori	 is	by	 far	 the	most	 frequently	14	
observed	 gastric	 infection	 in	 humans,	 non-H.	 pylori	 Helicobacter	 species	 (NHPH)	15	
infections	 of	 human	hosts	 have	been	 identified	 since	 at	 least	 the	mid-1990s.	 The	16	
identification	 of	 these	 organisms	 remains	 a	 challenge,	 and	 relies	 on	 molecular	17	
microbiological	techniques	that	are	not	routinely	available.		18	
Although	 NHPH	 infections	 	 are	 frequently	 	 reported	 to	 occur	 in	 association	 with	19	
gastritis,	 different	 studies	 have	 yielded	 conflicting	 results	 as	 to	 their	 significance	20	
(Flahou	et	al,	2013;	Liu	et	al,	2015).	Understanding	the	contribution	of	NHPH	species	21	
to	gastritis	is	further	complicated	by	the	occurrence	of	mixed	NHPH	infections,	by	the	22	
heterogeneity	 of	 NHPH	 strains,	 by	 the	 nomenclature	 of	 these	 species,	 and	 the	23	
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inability	 to	 cultivate	many	of	 them.	 For	 example,	 long	 spiral-shaped	bacteria	 that	1	
were	first	recognized	as	microscopically	different	from	H.	pylori	were	recognized	in	2	
human	gastric	 biopsies	 and	named	Gastrospirillum	hominis	 (McNulty	 et	 al,	 1989).	3	
These	organisms	were	subsequently	reclassified	as	Helicobacter	heilmannii	based	on	4	
16S	RNA	analysis,	of	which	there	are	at	 least	two	strains	(Heilmann	and	Borchard,	5	
1991).	 Many	 species	 of	 spiral-shaped	 NHPHs	 have	 since	 been	 recognized	 in	 the	6	
stomachs	of	animals	(as	discussed	in	more	detail	below).		7	
The	 most	 robust	 data	 for	 the	 pathogenicity	 of	 NHPH	 involve	 MALT	 lymphoma	8	
formation.	 H.	heilmannii-associated	MALT	 lymphoma	was	 first	 described	 in	 2000.	9	
Following	this,	a	large	study	examining	the	prevalence	of	MALT	lymphoma	in	263,680	10	
H.	pylori	infected	people,	and	in	543	NHPH	infected	people,	demonstrated	an	odds	11	
ratio	of	2.2	(95%	CI	1.1	to	4.5)	for	developing	gastric	MALT	lymphoma	in	individuals	12	
infected	with	NHPH	rather	than	with	H.	pylori	(Stolte	et	al,	2002).	This	organism	has	13	
also	been	described	in	association	with	individuals	with	chronic	gastritis	(Heilmann	14	
and	Borchard,	1991).	These	observations	suggest	 that	NHPH	play	a	 role	 in	human	15	
disease	development,	and	might	 in	some	cases	be	as	pathogenic	as	H.	pylori.	The	16	
additional	challenge	of	 identifying	 these	organisms	suggests	 that	 there	could	be	a	17	
group	of	individuals	with	gastric	pathology	due	to	unidentified	NHPH,	representing	18	
an	unmet	clinical	need.		19	
Naturally	occurring	gastric	Helicobacter	infections	in	non-human	mammals	20	
Whilst	the	association	of	H.	pylori	with	humans	has	been	extensively	studied	over	the	21	
past	4	decades,	significantly	less	has	been	published	on	the	association	of		H.	pylori,	22	
or	 other	Helicobacter	 species	with	 different	mammalian	 hosts.	 The	 data	 that	 are	23	
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available	suggest	a	spectrum	of	pathogenicity	for	different	Helicobacter	species,	as	1	
well	as	a	spectrum	of	susceptibility	for	gastric	pathology	in	different	host	organisms.	2	
A	better	understanding	of	these	comparative	biological	responses	may,	in	the	future,	3	
offer	insights	into	the	mechanisms	that	underlie	human	disease.	4	
Forty	five	species	of	Helicobacter	have	been	detected	by	PCR	in	fecal	samples	from	5	
150	vertebrate	species,	demonstrating	their	colonization	of	the	digestive	system	of	a	6	
wide	 range	 of	 domesticated	 and	 wild	 vertebrate	 species	 (Schrenzel	 et	 al,	 2010).	7	
Spontaneous	gastric	 colonization	by	NHPH	has	also	been	demonstrated	 in	 several	8	
mammalian	species	(Table	1),	leading	to	speculation	that	all	mammals	harbor	one	or	9	
more	Helicobacter	species	as	part	of	their	natural	gastric	flora	(Brown	et	al,	2007).		10	
When	examining	 the	evidence	 for	NHPH-induced	gastric	 lesions	 in	animal	species,	11	
various	factors	need	to	considered,	such	as	differences	in	gastric	morphology,	and	in	12	
the	 distribution	 and	 site	 of	 gastric	Helicobacters	 among	 some	 animal	 species	 and	13	
humans.	 Furthermore,	 the	 sequential	 pathological	 lesions	 that	 lead	 to	14	
adenocarcinoma	formation	in	humans,	as	described	by	Correa’s	model	(see	Glossary,	15	
Box	 1),	 have	 rarely	 been	 established	 in	 clinical	 veterinary	 species	 (Amorim	 et	 al,	16	
2016),	in	which	gastric	cancer	is	rare.	Exceptions	to	this	include:	ferrets	colonized	by	17	
H.	 mustalae,	 which	 undergo	 a	 similar	 sequence	 of	 pathology	 that	 culminates	 in	18	
gastric	 adenocarcinoma	 formation	 (Fox	 et	 al,	 1990;	 Fox	 et	 al,	 1997);	 Mongolian	19	
gerbils	 infected	with	H.	pylori,	which	develop	some	specific	pre-neoplastic	 lesions,	20	
including	 intestinal	metaplasia	 (Honda	et	al,	1998b);	and	Syrian	hamsters	 infected	21	
with	H.	aurati	(Patterson	et	al,	2000).		22	
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In	veterinary	medicine,	dogs	and	cats	frequently	undergo	gastric	biopsy	to	investigate	1	
unresolved	gastrointestinal	disease.	In	both	species,	NHPHs	are	frequently	observed,	2	
genetic	studies	show	that	these	organisms	are	often	present	as	a	mixed	infection	of	3	
different	NHPHs	(Priestnall	et	al,	2004)	with	H.	felis,	H.	heilmannii,	H.	bizzozeronii,	4	
and	H.	salomonis	being	the	most	commonly	identified	species	(Canejo-Teixeira	et	al,	5	
2014;	Priestnall	et	al,	2004;	Van	den	Bulck	et	al,	2005).		6	
Despite	NHPHs,	 including	H.	felis,	being	commonly	 identified	 in	dogs	and	cats	and	7	
being	associated	with	gastritis	(Shiratori	et	al,	2016)	and	with	gastric	MALT	lymphoma	8	
in	 humans	 (Stolte	 et	 al,	 2002),	 genetic	 studies	 have	 shown	 limited	 evidence	 for	9	
zoonosis.	The	most	frequently	isolated	H.	heilmannii	from	dogs	and	cats	are	distinct	10	
from	the	type	1	H.	heilmannii	identified	in	human	MALT	lymphoma	(Priestnall	et	al,	11	
2004).	However,	there	is	evidence	of	anthroponosis	in	the	H.	pylori	infection	of	cats;	12	
infection	 has	 only	 been	 reported	 in	 cat	 colonies	 that	 live	 in	 proximity	 to	 humans	13	
(Canejo-Teixeira	et	al,	2014).	14	
In	 dogs,	 lymphoplasmacytic	 gastritis	 is	 commonly	 observed	 in	 association	 with	15	
NHPHs	 (Neiger	 and	 Simpson,	 2000).	 However,	 there	 is	 no	 evidence	 to	 link	16	
conclusively	NHPH	 infection	with	 this	gastric	pathology.	 Indeed,	NHPH	 infection	 is	17	
present	in	67-86%	of	clinically	healthy	dogs,	and	in	61-100%	of	animals	presenting	18	
with	chronic	vomiting	(Amorim	et	al,	2016).	A	small-scale	study	reported	that	NHPHs	19	
are	found	in	association	with	all	cases	of	canine	gastric	polyps	(Taulescu	et	al,	2014).	20	
Similarly,	NHPHs	have	been	found	in	the	stomach	of	42-100%	of	healthy	cats,	and	in	21	
53-76%	of	those	presenting	with	clinical	signs	of	gastrointestinal	disease	(Norris	et	al,	22	
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1999).	It	is	hypothesized	that	these	infections	play	a	role	in	the	development	of	feline	1	
gastric	lymphoma	(Bridgeford	et	al,	2008b).	2	
H.	suis	is	detected	in	the	stomach	of	up	to	80%	of	pigs	at	the	time	of	slaughter,	with	3	
ulceration	and	hyperkeratosis	of	the	pars	esophagea	(see	Glossary,	Box	1)	present	in	4	
20-90%	 of	 slaughtered	 pigs	 (De	 Bruyne	 et	 al,	 2012).	 Although	 some	 studies	 have	5	
associated	H.	suis	with	increased	severity	of	gastritis	and	with	reduced	weight	gain	in	6	
pigs	(De	Bruyne	et	al,	2012),	gastritis		is	likely	to	be	multi-factorial	and	also	involves	7	
feed	particle	size,	highly	fermentable	carbohydrates,	and	stress	factors.	Interestingly,	8	
H.	suis	is	the	most	commonly	isolated	NHPH	found	in	human	stomachs,	suggesting	9	
the	potential	for	zoonotic	transmission.	10	
Helicobacter-like	 DNA	 has	 also	 been	 isolated	 from	 the	 stomach	 of	 thoroughbred	11	
horses	 (Contreras	 et	 al,	 2007),	 although	 the	 role	 of	Helicobacter	 in	 gastritis	 and	12	
gastric	ulceration	 in	horses	 is	unclear.	Horses	possess	a	much	 larger	proportion	of	13	
non-glandular	squamous	mucosa	than	do	pigs,	which	constitutes	the	proximal	half	of	14	
the	 stomach	 mucosa,	 and	 gastric	 ulceration	 is	 present	 in	 up	 to	 86%	 of	 training	15	
racehorses	(Begg	and	O'Sullivan,	2003).	The	high	proportion	of	horses	suffering	from	16	
ulceration	that	undergo	strenuous	exercise	suggests	 that	stress,	management	and	17	
training	practices	are	likely	risk	factors	(Murray	et	al,	1996).	Ulceration	occurs	most	18	
commonly	in	the	non-glandular	portion	of	the	stomach,	close	to	the	transition	of	the	19	
non-glandular	and	glandular	stomach,	although	pyloric	ulceration	is	also	observed	in	20	
47%	of	horses	(Begg	and	O'Sullivan,	2003).	21	
Up	to	100%	of	adult	ferrets	harbor	gastric	H.	mustelae,	(Fox	et	al,	1990),	however,	22	
this	organism	is	rarely	found	in	ferrets	of	less	than	6	weeks	of	age	(Fox	et	al,	1988).	23	
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The	incidence	of	gastric	ulceration	in	ferrets	varies	between	1.4	and	35%	(Andrews	1	
et	 al,	 1979),	 and	 H.	 mustelae	 has	 also	 been	 associated	 with	 adenocarcinoma	2	
formation	(Fox	et	al,	1997)	and	with	gastric	lymphoma	development	(Erdman	et	al,	3	
1997)	in	this	species.	4	
Captive	rhesus	macaques	are	commonly	infected	with	H.	pylori,	(Drazek	et	al,	1994),	5	
and	non-human	primates	have	been	used	as	models	of	H.	pylori	 infection.	Indeed,	6	
rhesus	 macaques	 in	 social	 housing	 rapidly	 acquire	 H.	 pylori	 from	 other	 infected	7	
individuals	 (Solnick	 et	 al,	 2003).	 Neonatal	 rhesus	 macaques	 are	 more	 commonly	8	
infected	with	H.	pylori	when	born	to	infected	mothers,	suggesting	that	close	contact	9	
in	the	peripartum	period	is	important	for	bacterial	transmission	(Solnick	et	al,	2003),	10	
potentially	 via	 an	 oral-oral	 route.	 (Solnick	 et	 al,	 2006).	 The	 induced	 pathology	 in	11	
rhesus	 macaques	 is	 also	 very	 similar	 to	 that	 observed	 in	 humans	 with	 H.	 pylori	12	
infection	(Haesebrouck	et	al,	2009).	However,	no	NHPH	species	have	been	uniquely	13	
associated	with	non-human	primate	gastric	colonization,	although	H.	suis	has	been	14	
demonstrated	 in	 captive	 mandrills	 (Papio	 sphinx),	 cynomolgus	 monkeys	 (Macaca	15	
fasicularis),	and	in	a	rhesus	macaque	(Macaca	mulatta)	from	a	zoo	(Haesebrouck	et	16	
al,	2009).	The	question	of	whether	these	NHPHs	are	implicated	in	the	development	17	
of	 gastritis	 in	 non-human	 primates	 remains	 unknown.	 More	 recently,	 a	 study	18	
identified	a	high	 incidence	of	gastric	adenocarcinoma	 in	a	captive	colony	of	 sooty	19	
mangabeys	(Cercebus	atys)	(Sharma	et	al,	2011).	This	colony	has	subsequently	been	20	
shown	to	be	heavily	colonized	with	H.	suis	by	both	fluorescence	in-situ	hybridization	21	
and	16S	ribosomal	RNA	sequencing	(Esmail	et	al,	2016).	This	is	the	first	evidence	of	22	
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naturally	 occurring	 Helicobacter	 associated	 with	 gastric	 carcinogenesis	 in	 a	 non-1	
human	primate.	2	
In-vivo	models	of	Helicobacter	induced	gastric	pathology	3	
Because	 of	 the	 breadth	 of	 potential	 pathological	 outcomes	 that	 can	 follow	 an	H.	4	
pylori	infection,	no	single	animal	model	can	replicate	all	of	the	pathological	outcomes	5	
of	this	condition.	However,	as	we	discuss	in	more	detail	below,	models	do	exist	that	6	
can	replicate	each	of	the	potential	outcomes	of	H.	pylori	infection	in	humans	(Figure	7	
4).		8	
Models	of	superficial	gastritis	9	
The	acute	phase	of	Helicobacter	gastritis	has	rarely	been	the	focus	of	research,	due	10	
in	part	to	the	small	number	of	reported	cases	in	the	human	literature.	Where	data	11	
have	been	published,	they	have	focused	on	defining	the	bacterial	and	host	factors	12	
that	 influence	Helicobacter	 colonization	and	 the	acute	 cytokine	milieu	 induced	by	13	
these	bacterial	infections.	14	
Historic	studies	in	gnotobiotic	pigs	demonstrated	that	the	urease	enzyme	produced	15	
by	Helicobacter	bacteria	(Eaton	and	Krakowka,	1994)	and	their	functioning	flagellae	16	
are	essential	for	effective	colonization	of	the	gastric	mucosa	(Eaton	et	al,	1992).		17	
Experimental	infections	of	cats	with	H.	pylori	have	shown	that	active	colonization	of	18	
the	gastric	mucosa	occurs	readily,	and	that	a	chronic	gastritis	can	follow	(Fox	et	al,	19	
1995).	Independently,	researchers	characterized	the	acute	cytokine	response	of	cats	20	
born	into	a	colony	of	H.	pylori	infected	animals.	In	this	study	(Straubinger	et	al,	2003),	21	
the	researchers	compared	animals	born	into	their	H.	pylori	infected	colony	to	specific	22	
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pathogen	 free	 (SPF)	animals	bought	 into	 the	animal	unit.	They	demonstrated	that	1	
animals	in	the	infected	colony	became	colonized	with	H.	pylori	passively	by	14	weeks	2	
of	 age,	 and	 that	 this	was	associated	with	an	 immune	 response	dominated	by	 the	3	
expression	of	cytokines	IFN-g,	IL-1a,	IL-1b,	and	IL-8.	As	with	the	other	large	animal	4	
models	of	H.	pylori	infection,	these	experiments	benefit	from	the	availability	of	serial	5	
endoscopic	evaluation,	but	are	challenging	to	perform	due	to	the	ethical	and	cost	6	
limitations	associated	with	using	large	animals	in	experimental	procedures.	7	
More	 recently,	Mongolian	 gerbils	 have	been	used	 to	 investigate	host	 factors	 that	8	
allow	 optimal	 gastric	 colonization	 (Bucker	 et	 al,	 2012).	 Gastrostomies	 were	9	
performed	under	terminal	anesthesia	to	place	an	intraluminal	pH	probe,	and	an	auto-10	
titrator	into	the	stomach.	The	authors	used	this	system	to	recapitulate	the	effect	on	11	
gastric	pH	of	a	meal	whilst	simultaneously	inoculating	H.	pylori.	Three	physiological	12	
conditions	were	 replicated	 using	 this	 apparatus.	 First,	 it	 replicated	 the	 gastric	 pH	13	
profile	observed	in	newborn	human	infants,	who	have	a	persistently	elevated	gastric	14	
pH	due	to	the	large	buffering	capacity	of	a	milk-based	diet	and	relatively	low	gastric	15	
acid	secretion.	Second,	it	replicated	the	pH	profile	of	young	children,	in	whom	gastric	16	
pH	is	transiently	elevated	due	to	the	buffering	capacity	of	a	high	milk	diet,	but	then	17	
lowered	to	pH	1-2	by	gastric	acid	secretion.	And	finally,	 it	replicated	the	profile	of	18	
adults,	in	whom	luminal	pH	remains	low	throughout	the	post-prandial	period	due	to	19	
high	acid	secretion	and	the	relatively	low	buffering	capacity	of	food.	The	pH	profile	20	
similar	 to	 that	 of	 young	 children	enhanced	 the	 ability	 of	H.	 pylori	 to	 colonize	 the	21	
stomach	up	to	15-fold,	supporting	other	evidence	that	the	commonest	mode	of	H.	22	
pylori	colonization	is	through	vertical	transmission	from	parent	to	child	(Suerbaum	23	
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and	Josenhans,	2007).	This	model	provides	the	potential	to	look	at	other	elements	of	1	
gastric	microbiotal	colonization.	For	instance,	does	an	achlorhydric	stomach	offer	a	2	
niche	 for	 colonization	 with	 other	 non-Helicobacter	 organisms,	 and	 if	 so	 does	 co-3	
infection	with	H.	pylori	help	or	hinder	this	process?	4	
The	 immediate	 host	 response	 to	 colonization	 with	 Helicobacter	 has	 also	 been	5	
modelled	 by	 the	 introduction	 of	 H.	 pylori-derived	 lipopolysaccharide	 into	 the	6	
stomachs	of	Sprague-Dawley	rats.	This	induced	an	inflammatory	cell	infiltrate	typified	7	
by	 lymphocyte	 infiltration,	 and	 increased	 gastric	 epithelial	 cell	 apoptosis	 over	 the	8	
course	 of	 four	 days.	 Rather	 than	 recapitulating	 the	 pathology	 observed	 in	 acute	9	
human	H.	pylori	 infection,	 the	pathological	description	of	 this	model	was	more	 in	10	
keeping	 with	 the	 pathology	 observed	 in	 people	 with	 chronic	 superficial	 gastritis	11	
(Slomiany	et	al,	1998).		12	
These	studies	have	remained	relatively	niche	areas	of	investigation,	and	to	date	have	13	
not	 been	 replicated	 by	 other	 groups.	 Significant	 research	 questions	 remain,	14	
particularly	regarding	the	initial	host	responses	to	H.	pylori	exposure.	15	
Models	of	gastric	ulceration	16	
In-vivo	 models	 of	 gastric	 ulceration	 induced	 by	 Helicobacter	 infection	 alone	 are	17	
limited	to	gnotobiotic	pigs,	Mongolian	gerbils,	and	isolated	reports	of	murine	gastric	18	
ulceration.	Several	groups	have	independently	shown	that	gnotobiotic	pigs	develop	19	
ulcers	at	the	junction	between	the	squamous	epithelium	of	the	pars	esophagea	and	20	
columnar	mucosa	of	the	true	stomach,	following	infection	with	Helicobacter	species	21	
harvested	 from	 commercially	 reared	 pigs	 (Krakowka	 et	 al,	 1995;	 Krakowka	 et	 al,	22	
2005;	Kronsteiner	et	al,	2013).	These	models	have	helped	to	confirm	the	association	23	
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between	Helicobacter	colonization	and	peptic	ulceration,	but	have	not	been	adopted	1	
more	widely	for	mechanistic	studies.	2	
Mongolian	 gerbils	 reportedly	 develop	 a	 wide	 spectrum	 of	 Helicobacter	 induced	3	
pathologies,	including	gastric	ulceration.	For	example,	Honda	et	al	reported	that	4	of	4	
5	gerbils	developed	gastric	ulceration	six	months	after	colonization	with	the	CagA-5	
positive	 (see	Glossary,	 Box	 1)	H.	 	 pylori	 strain,	 ATCC-43504	 (Honda	 et	 al,	 1998a).	6	
Independently,	Ogura	and	colleagues	identified	gastric	ulceration	in	22	of	23	gerbils	7	
infected	with	the	TN2	strain	of	H.	pylori	for	62	weeks.	When	the	H.	pylori	virulence	8	
factor	CagE	was	deleted,	none	of	the	22	infected	animals	developed	gastric	ulceration	9	
in	the	same	timescale,	demonstrating	the	utility	of	Mongolian	gerbils	for	modelling	10	
gastric	ulceration,	and	the	value	of	this	model	for	characterizing	the	virulence	factors	11	
of	H.	pylori	(Ogura	et	al,	2000).	12	
Most	 of	 the	 literature	 reporting	 H.	 pylori	 colonization	 of	 mice	 suggests	 that	13	
colonization	is	usually	transient,	and	if	persistent,	that	it	is	often	associated	with	only	14	
mild	gastritis	(Lachman	et	al,	1997).	In	contrast,	Kaur	et	al.	reported	a	model	of	gastric	15	
ulceration	following	colonization	of	female	C57BL/6	mice	with	H.	pylori	DSMZ	10242	16	
for	8	weeks	(Kaur	et	al,	2014).	This	study	reported	multifocal	gastric	antral	ulceration	17	
with	relatively	deep	ulcers	at	8	weeks,	which,	if	 left	untreated	did	not	heal.	Whilst	18	
this	study	contrasts	with	much	of	 the	 literature,	 it	might	reflect	how	factors	 in	an	19	
individual	 laboratory,	 in	 particular	 the	 baseline	 microbiota,	 can	 influence	 the	20	
outcome	of	infection	in	different	institutions.		21	
A	 more	 established	 method	 for	 investigating	 the	 effect	 of	 H.	 pylori	 on	 gastric	22	
ulceration	 has	 been	 to	 investigate	 the	 impact	 of	H.	 pylori	 infection	 on	 chemically	23	
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induced	 gastric	 ulcers.	 For	 instance,	 rats	 administered	 acetic	 acid	 to	 the	 serosal	1	
surface	 of	 the	 stomach	 develop	 ulcers	 that	 heal	 over	 several	 weeks.	 Gastric	2	
colonization	with	both	CagA+	(ATCC	43504)	(Bui	et	al,	1991)	and	CagA-	(AH69)	(Li	et	3	
al,	 1997)	 strains	 of	H.	 pylori,	 impairs	 the	 healing	 of	 acetic	 acid-induced	 ulcers	 in	4	
Sprague-Dawley	rats.	In	this	model,	extracted	H.	pylori	surface	proteins	(Brzozowski	5	
et	al,	1999)	also	impaired	the	healing	of	gastric	ulcers,	suggesting	that	a	response	to	6	
bacterial	components,	and	not	necessarily	to	the	presence	of	live	Helicobacter,	can	7	
impair	mucosal	healing	following	gastric	injury	(Brzozowski	et	al,	1999).	8	
Models	 of	 gastric	 adenocarcinoma	 and	 its	 precursor	 lesions:	 large	 and	 small	9	
mammals	10	
Gastric	carcinogenesis	has	been	the	most	extensively	studied	outcome	of	H.	pylori	11	
infection,	and	it	has	the	most	diverse	array	of	 in-vivo	models,	several	of	which	are	12	
used	 in	 laboratories	across	 the	world.	Much	of	 the	original	work	 investigating	 the	13	
pathogenesis	of	Helicobacter-induced	gastric	cancer	was	performed	in	large	animals.		14	
Large	 animal	models	 of	 gastric	 pathology	 offer	 the	 opportunity	 to	 perform	 serial	15	
endoscopic	biopsies	during	an	experiment.	This	allows	investigators	to	document	the	16	
temporal	development	of	gastric	pre-neoplasia	in	individual	animals,	and	has	been	17	
adopted	in	Beagle	dogs	(Rossi	et	al,	1999)	and	Rhesus	monkeys	(Liu	et	al,	2009).	18	
In	one	such	study	(Rossi	et	al,	1999),	conventionally	housed	dogs	were	infected	with	19	
a	CagA+	strain	of	H.	pylori	(SPM326s)	and	underwent	endoscopic	evaluation	1,	2,	4,	20	
8,	12,	18	and	24	weeks	after	 infection.	 From	8	weeks,	 chronic	 superficial	 gastritis	21	
developed,	with	progressive	changes	observed	in	the	gastric	mucin	composition,	in	22	
keeping	 with	 functional	 gastric	 atrophy.	 The	 authors	 interpreted	 this	 as	 the	23	
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development	 of	 early	 pre-neoplastic	 pathology.	 The	 study	 also	 demonstrated	1	
progression	towards	atrophic	gastritis;	however,	it	is	not	possible	to	predict	whether	2	
more	 advanced	 pre-neoplastic	 lesions	would	 subsequently	 develop	 in	 this	model.	3	
This	study	was	also	compromised	by	a	lack	of	detail	about	the	pre-infection	gastric	4	
microbiota	of	the	animals	used	in	this	study;	they	were	demonstrated	to	be	H.	pylori	5	
seronegative,	but	pre-infection	gastric	colonization	was	not	assessed	for	H.	pylori	or	6	
for	other	NHPHs.	7	
H.	 pylori	 infection	 of	 rhesus	macaques	 has	 been	 studied	 in	 combination	with	 the	8	
administration	of	the	ethylating	agent,	N-ethyl-N'-nitro-N-nitrosoguanidine	(ENNG).	9	
ENNG	is	similar	to	N-nitroso	compounds	present	in	traditional	Far	Eastern	diets,	and	10	
is	proposed	to	be	a	potential	dietary	risk	factor	for	developing	gastric	cancer	(Seel	et	11	
al,	 1994).	 Rhesus	 macaques	 were	 observed	 over	 5	 years	 following	 H.	 pylori	12	
colonization,	 and	 gastroscopy	 was	 performed	 quarterly.	 Neither	 the	 continuous	13	
administration	 of	 ENNG	 in	 food	 ad-libitum,	 nor	H.	 pylori	 infection	 alone	 induced	14	
gastric	pre-neoplasia.	However,	the	administration	of	both	agents	together	induced	15	
intestinal	 type	 metaplasia	 after	 two	 years	 of	 treatment,	 and	 more	 advanced	16	
neoplasia,	 including	 high-grade	 dysplasia,	 in	 one	 animal	 after	 5	 years.	 This	 study	17	
demonstrates	synergy	between	ENNG	and	H.	pylori,	but	the	study	design	was	unable	18	
to	 determine	 whether	 both	 agents	 are	 essential	 for	 gastric	 carcinogenesis,	 or	19	
whether	one	carcinogen	accelerated	the	effect	of	the	other	(Liu	et	al,	2009).	20	
	Although	studies	using	large	animal	models	provided	insights	into	the	development	21	
of	Helicobacter	induced	gastric	cancer,	they	have	not	been	widely	adopted	due	to	the	22	
need	for	specialized	animal	facilities	and	the	high	associated	costs.	As	a	result,	rodent	23	
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models	are	most	commonly	used.	In	particular,	Mongolian	gerbil	and	murine	models	1	
have	been	used	frequently	in	different	laboratories	to	investigate	diverse	aspects	of	2	
gastric	carcinogenesis.		3	
Both	mice	and	gerbils	develop	stereotypical,	pre-neoplastic	pathology	in	response	to	4	
Helicobacter	 infection.	 Whilst	 the	 pathways	 observed	 in	 humans	 and	 gerbils	 are	5	
similar,	there	is	a	difference	during	the	metaplastic	phase	of	gastric	pre-neoplasia	in	6	
mice.	In	humans	and	gerbils,	the	commonest	metaplasia	is	intestinal	type	metaplasia.	7	
This	 is	 characterized	 by	 the	 presence	 of	 goblet	 cells	 and	 by	 the	 expression	 of	8	
appropriate	 intestinal	markers,	such	as	trefoil	 factor	3	(TFF3)	and	mucin	2	(MUC2)	9	
(Ectors	 and	 Dixon,	 1986),	 as	 well	 as	 by	 the	 intestinal	 differentiation	 regulating	10	
transcription	factor	CDX2	(Barros	et	al,	2011;	Silberg	et	al,	2002).	11	
Another	 metaplastic	 lesion,	 defined	 as	 spasmolytic	 polypeptide	 expressing	12	
metaplasia	(SPEM),	is	less	frequently	identified	in	people	with	gastric	pre-neoplasia.	13	
It	 is	characterized	by	a	phenotype	similar	 to	 the	secreting	Brunner’s	glands	of	 the	14	
intestine,	or	to	deep	antral	gland	cells	that	express	Muc6	and	trefoil	factor	2	(TFF2,	15	
or	spasmolytic	polypeptide)	(Weis	and	Goldenring,	2009).	In	gerbils,	the	distribution	16	
of	 these	 lesions	 is	 similar	 to	 that	 observed	 in	 humans	 (Yoshizawa	 et	 al,	 2007),	17	
whereas	 C57BL/6	 mice	 infected	 with	 H.	 felis	 develop	 a	 predominantly	 SPEM	18	
response,	with	little	or	no	evidence	of	intestinal	type	metaplasia	(Shimizu	et	al,	2016;	19	
Weis	and	Goldenring,	2009).	20	
When	colonized	by	H.	pylori	and	by	several	other	NHPH	strains,	including	H.	felis,	H.	21	
bizzozeroni	and	H.	suis	(De	Bock	et	al,	2006a;	De	Bock	et	al,	2006b;	Liang	et	al,	2015;	22	
Nakamura	 et	 al,	 2007),	 Mongolian	 gerbils	 reportedly	 develop	 advanced	 pre-23	
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malignant	lesions.	However,	the	use	of	this	organism	is	complicated	by	problems	of	1	
experimental	reproducibility.	For	example,	Watanabe	and	colleagues	(Watanabe	et	2	
al,	 1998)	 reported	 that	 5	 out	 of	 5	 gerbils	 infected	with	 the	CagA+	H.	 pylori	 strain	3	
TN2GF4	in	a	standard	animal	house	environment	for	52	weeks	developed	intestinal	4	
metaplasia,	 although	 10	 of	 27	 gerbils	 infected	 for	 62	 weeks	 developed	 invasive	5	
adenocarcinomas.	In	contrast,	(Elfvin	et	al,	2005)	studied	gerbils	that	were	colonized	6	
with	 either	H.	 pylori	 SS1	or	 TN2GF4	 and	maintained	 in	 a	 SPF	 facility	 for	 up	 to	 18	7	
months.	None	of	these	animals	developed	invasive	adenocarcinoma,	and	only	2	of	5	8	
infected	animals	at	12	months,	and	3	of	10	infected	animals	at	18	months,	developed	9	
intestinal	metaplasia.		10	
Because	 the	 Mongolian	 gerbil	 is	 outbred,	 the	 genetic	 backgrounds	 of	 animals	11	
supplied	to	different	laboratories	up	to	a	decade	apart,	will	have	been	divergent.	The	12	
conditions	within	different	animal	units	might	also	have	contributed	to	differences	in	13	
these	studies,	particularly	in	terms	of	diet	and	resident	microbiota.	In	keeping	with	14	
other	studies	investigating	the	role	of	the	microbiota	in	host	pathology	(Justice	and	15	
Dhillon,	2016;	Schofield	et	al,	2016),	 these	observations	demonstrate	some	of	 the	16	
challenges	of	 comparing	 in-vivo	 studies	performed	 in	different	environments,	 and	17	
challenge	 the	 received	 wisdom	 that	 experimental	 results	 should	 always	 be	18	
reproducible	in	different	settings.	Fully	understanding	why	these	apparently	similar	19	
experiments	resulted	in	divergent	outcomes	could	offer	insights	into	the	mechanisms	20	
that	drive	the	development	of	gastric	pre-neoplasia	in	the	gerbil.	21	
The	Mongolian	gerbil	has	been	particularly	useful	for	identifying	Helicobacter-specific	22	
and	environmental	factors	that	influence	the	development	of	gastric	cancer.	It	has	23	
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been	used	to	demonstrate	the	carcinogenic	potential	of	both	H.	pylori	(Watanabe	et	1	
al,	1998)	and	H.	felis	(Court	et	al,	2002;	De	Bock	et	al,	2006a;	De	Bock	et	al,	2006b),	2	
and	 that	H.	bizzozeronii	 and	H.	 salomonis	 (De	Bock	 et	al,	 2006b)	are	 less	 likely	 to	3	
induce	 gastric	 pre-neoplasia	 in	 this	 species.	 In	 addition,	 several	 studies	 have	4	
identified	 that,	as	 in	human	epidemiological	 studies	 (Wang	 et	al,	 2009),	 	high-salt	5	
diets	promote	the	development	of	H.	pylori	induced	gastric	pre-neoplastic	pathology	6	
in	gerbils	(Bergin	et	al,	2003;	Kato	et	al,	2006;	Nozaki	et	al,	2002).	7	
The	 Mongolian	 gerbil	 has	 also	 been	 used	 to	 adapt	 H.	 pylori	 strains	 to	 a	 rodent	8	
environment.	 This	 has	been	demonstrated	best	 by	 the	passage	of	H.	pylori	 B128,	9	
derived	from	a	patient	with	gastric	ulceration,	through	a	male	gerbil	for	3	weeks.	H.	10	
pylori	was	subsequently	re-cultured	from	this	animal’s	stomach	and	described	as	H.	11	
pylori	strain	7.13,	which	 is	more	pathogenic	 than	strain	B128.	 	Six	of	eight	gerbils	12	
infected	 with	 H.	 pylori	 7.13	 developed	 gastric	 adenocarcinoma	 8	 weeks	 after	13	
inoculation,	in	comparison	to	none	in	the	B128	group	(Franco	et	al,	2005).	The	same	14	
researchers	 demonstrated	 that	 this	 phenotype	 was	 essentially	 reproducible,	 and	15	
preventable	by	eradication	of	H.	pylori	(Romero-Gallo	et	al,	2008).	The	7.13	strain	has	16	
been	further	characterized	by	genome	sequencing	(Asim	et	al,	2015),	providing	data	17	
that	will	help	to	advance	our	future	understanding	of	H.	pylori	pathogenicity.	18	
The	 laboratory	mouse	 is	 the	 other	 rodent	 used	 extensively	 to	model	 gastric	 pre-19	
neoplasia.	 H.	 pylori	 colonization	 of	 C57BL/6	 inbred	 mice	 leads	 to	 gastritis	 with	20	
epithelial	cell	hyperplasia,	but	this	does	not	progress	to	dysplasia	or	to	cancer	(Lee	et	21	
al,	 1997).	 However,	 the	 colonization	 of	 C57BL/6	mice	with	H.	 felis	 is	 consistently	22	
shown	to	lead	to	gastric	pre-neoplasia,	and	when	infections	have	persisted	for	13-15	23	
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months,	 adenocarcinomas	 have	 been	 reported	 (Fox	 et	 al,	 2002).	 This	 outcome	 is	1	
specific	to	the	C57BL/6	genetic	background.	2	
	Other	 strains	 of	 in-bred	 mouse,	 including	 Balb/c,	 respond	 differently	 to	 H.	 felis	3	
infection	.	This	strain	can	be	substantially	colonized	by	H.	felis,	but	does	not	develop	4	
gastric	 pre-neoplastic	 pathology	 (Wang	 et	 al,	 1998).	 The	 mechanisms	 underlying	5	
these	differences	between	mouse	strains	are	attributable	to	differences	in	immune	6	
response.	 C57BL/6	 mice	 demonstrate	 a	 Th1	 polarized	 immune	 response,	 whilst	7	
Balb/c	mice	have	a	more	Th2	polarized	response	to	H.	felis	colonization,	which	allows	8	
infection	to	persist	but	does	not	promote	chronic	epithelial	disruption	(Wang	et	al,	9	
1998).	 The	 B6129	 mouse,	 generated	 by	 crossing	 C57BL/6	 with	 129S6/SvEv,	 is	10	
particularly	sensitive	to	Helicobacter	induced	pathology	triggered	by	H.	felis.	In	these	11	
mice,	gastric	 intraepithelial	neoplasia	developed	8	months	after	H.	pylori	 infection	12	
whilst	malignant	 tumors	developed	after	 approximately	 	15	months	 (Rogers	 et	 al,	13	
2005).	14	
In	addition	to	the	models	of	gastric	cancer	induced	solely	by	Helicobacter	infection,	15	
several	chemically	induced	gastric	cancer	models	are	accelerated	by	co-infection	with	16	
H.	 pylori.	 These	 include	 mice	 and	 Mongolian	 gerbils	 infected	 with	 H.	 pylori	 and	17	
treated	with	N-methyl-N-nitrosourea,	(MNU),	and	Mongolian	gerbils	infected	with	H.	18	
pylori	and	treated	with	methylnitronitrosoguanidine	(MNNG).	In	Mongolian	gerbils,	19	
the	 co-administration	 of	 H.	 pylori	 with	 the	 carcinogen	 MNNG	 	 accelerated	 the	20	
carcinogenic	process,	leading	to	invasive	cancer	in	60–80%	of	animals	treated	for	1	21	
year	 (Maruta	et	al,	2001;	Maruta	et	al,	2000;	Tatematsu	et	al,	1998).	 In	mice,	 the	22	
effect	of	co-administering	MNU	and	H.	pylori	is	less	clear,	with	contrasting	reports	of	23	
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either	 synergy	 between	 the	 two	 stimuli	 (Han	 et	 al,	 2002),	 or	 no	 additional	 effect	1	
above	chemical	carcinogen	alone	(Nakamura	et	al,	2002).	2	
	3	
Transgenic	mouse	models	of	gastric	carcinogenesis	4	
Several	transgenesis	strategies	have	been	used	to	study	gastric	carcinogenesis.	These	5	
include	 the	 induction	 of	 spontaneous	 gastric	 atrophy,	 the	 expression	 of	H.	 pylori	6	
pathogenicity	 factors,	 and	 the	 overexpression	 of	 known	 oncogenes	 in	 the	 gastric	7	
mucosa.	 Transgenic	 animals	 have	 also	 been	 	 used	 to	 explore	 the	 role	 of	 specific	8	
molecular	 pathways	 that	 potentially	modulate	 gastric	 carcinogenesis.	 A	 complete	9	
description	 of	 the	 genetically	 engineered	mouse	models	 (GEMMs)	 used	 in	 gastric	10	
carcinogenesis	research	is	beyond	the	scope	of	this	article,	and	so	we	refer	readers	11	
to	another	recent	review	for	more	information	(Jiang	and	Yu,	2016).	Here,	we	focus	12	
on	the	best	characterized	of	these	models.	13	
Amongst	the	most	established	examples	of	transgenically	induced	gastric	atrophy	is	14	
the	 INS-Gas	 mouse	 model	 (also	 known	 as	 FVB-tg(rl1-hinsgas)	 (Wang	 and	 Brand,	15	
1992).	This	mouse	expresses	a	human	gastrin	mini-gene	under	the	control	of	the	rat	16	
insulin	promoter.	It	constitutively	expresses	gastrin	in	β-cells	of	the	pancreatic	islets,	17	
resulting	in	the	constitutive	overexpression	of	amidated	gastrin.	These	animals	are	18	
born	with	increased	numbers	of	parietal	cells	and	at	birth	hypersecrete	acid,	but	over	19	
the	first	5	months	of	life,	parietal	cell	numbers		fall	to	that	of	wild-type	animals.	Over	20	
longer	periods,	profound	gastric	atrophy	occurs,	and	a	proportion	of	these	animals	21	
develop	 spontaneous	 gastric	 cancers	 (Wang	 et	 al,	 2000).	 Helicobacter	 infection	22	
accelerates	 the	 gastric	 pathology	 observed	 in	 this	 mouse;	 85%	 of	 INS-Gas	 mice	23	
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infected	with	H.	felis	developed	gastric	cancers	7	months	after	infection	(Wang	et	al,	1	
2000).	 Similarly,	 when	 INS-Gas	 mice	 are	 infected	 with	 H.	 pylori,	 they	 exhibit	2	
significantly	more	severe	gastric	 inflammation	and	dysplasia	relative	to	uninfected	3	
controls.	 Interestingly,	 INS-Gas	 males	 are	 more	 severely	 affected	 by	 H.	 pylori	4	
infection	than	are	female	mice,	for	reasons	unknown,	and	in	the	same	study,	mice	5	
exposed	 to	 high	 dietary	 salt	 levels	 had	more	 severe	 gastric	 pathology	 relative	 to	6	
untreated	controls	(Fox	et	al,	2003).		7	
More	recently,	the	INS-Gas	mouse	has	been	used	to	characterize	the	role	that	the	8	
non-Helicobacter	microbiome	has	during	gastric	carcinogenesis.	INS-Gas	mice	bred	9	
and	maintained	in	a	germ-free	environment	did	not	develop	spontaneous	gastric	pre-10	
neoplasia,	while	otherwise	germ-free	mice	infected	with	H.	pylori	developed	fewer	11	
tumors	than	did	H.	pylori	infected	SPF	mice	(Lofgren	et	al,	2011).	Subsequently,	the	12	
same	group	demonstrated	that	a	limited	group	of	3	bacterial	species	is	sufficient	to	13	
restore	the	phenotype	of	SPF	mice	in	otherwise	germ-free	mice	(Lertpiriyapong	et	al,	14	
2014),	 and	 that	 co-infection	 with	 the	 intestinal	 roundworm	 Heligmosomoides	15	
polygyrus can	protect	 INS-Gas	mice	against	H.	pylori	 induced	gastric	pre-neoplasia	16	
(Whary	et	al,	2014).	This	protection	was	associated	with	an	increase	in	the	number	17	
of	forkhead	box	P3	(FoxP3)	positive	cells	in	the	gastric	corpus	of	mice.	Suggesting	a	18	
possible	shift	in	the	TReg	immune	response	to	H.	pylori	infection.	19	
The	 CEA/SV40	 T	 L5496	 mouse	 expresses	 the	 SV40	 T	 proto-oncogene	 under	 the	20	
control	 of	 a	 truncated	 carcinoembryonic	 antigen	 (CEA)	 promoter.	 Gastric	 tumors	21	
formed	in	all	mice,	with	dysplasia	evident	as	early	as	37	days	postnatally	and	with	22	
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animals	 becoming	 moribund	 due	 to	 gastric	 tumor	 burden	 by	 100	 -130	 days	1	
postnatally	(Thompson	et	al,	2000).		2	
Mice	 transgenically	 deficient	 for	mutT	 homolog-1	 (MTH1)	 are	 unable	 to	 process	3	
oxygen	 free	 radicals,	 which	 cause	 DNA	 damage,	 and	 are	 susceptible	 to	 several	4	
spontaneous	tumors,	including	gastric	tumors,	which	develop	over	~18	months.	14%	5	
(13	of	93)	MTH1	null	mice	developed	gastric	 tumors,	compared	with	4%	(4	of	90)	6	
littermate	controls	(Tsuzuki	et	al,	2001).		7	
In	Trefoil	factor	1	(TFF1)-deficient	mice,	the	structure	of	both	the	antral	and	corpus	8	
mucosa	 is	markedly	 altered	 from	birth.	 By	 five	months	 of	 age,	 all	TFF1	 null	mice	9	
exhibit	 adenomatous	 changes	 in	 the	 gastric	 mucosa,	 and	 30%	 have	 established	10	
adenocarcinomas	(Lefebvre	et	al,	1996).		11	
The	 C57BL/6J-tg(H/K_ATPase/hIL-1b)	 mouse	 overexpresses	 human	 interleukin	 1B	12	
(IL1B)	 under	 the	 control	 of	 the	 H+/K+	 ATPase	 	 β-subunit	 promoter,	 leading	 to	13	
expression	of	human	 IL1-b	exclusively	 in	parietal	cells.	 In	 this	model,	15%	of	male	14	
mice	 develop	 spontaneous	 tumors	 at	 14	 months	 of	 age,	 and	 disease	 severity	 is	15	
markedly	increased	by	infection	with	H.	felis	(Tu	et	al,	2008).		16	
Transgenic	 mutation	 of	 the	 IL6	 co-receptor,	 gp130,	 leads	 to	 a	 severe	 gastric	17	
phenotype	in	which	gastric	antral	adenomas	spontaneously	develop	over	the	first	6-18	
8	weeks	of	life,	and	subsequently	grow	and	spread	to	include	the	gastric	fundus	by	19	
48	weeks	of	age	(Judd	et	al,	2004;	Tebbutt	et	al,	2002).	Whilst	this	animal	does	not	20	
exhibit	 the	 classical	 pre-neoplastic	 pathology	 induced	by	Helicobacter	 infection,	 it	21	
may	have	relevance	to	H.	pylori	mediated	disease	as	CagA	status	has	been	shown	to	22	
influence	 gp130-mediated	 switching	 between	 Src	 homology	 region	 2-containing	23	
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protein	tyrosine	phosphatase	2	(SHP2)	/	extracellular	signal–regulated	kinases	(ERK)	1	
and	 Janus	 kinase	 (JAK)	 /	 Signal	 Transducer	 and	 Activator	 of	 Transcription	 (STAT)	2	
signaling	 cascades	 in-vitro	 (Lee	 et	 al,	 2010).	 Signalling	 through	 these	mechanisms	3	
influences	 a	 number	 of	 cellular	 processes	 that	 are	 altered	 in	 cancer,	 including	4	
regulation	 of	 cell	 proliferation	 and	 apoptosis,	 invasion	 and	 angiogenesis,	 and	5	
disruption	 of	 these	 pathways,	 either	 by	 direct	 mutagenesis,	 or	 through	 other	6	
mechanisms,	 have	 been	 identified	 in	 many	 different	 tumour	 types	 (Zhang	 et	 al,	7	
2015).	8	
Transgenic	expression	of	the	H.	pylori	virulence	factor	CagA	is	oncogenic	to	the	gastric	9	
mucosa,	 both	 when	 expressed	 constitutively	 throughout	 the	 animal	 under	 the	10	
control	of	the	beta-actin	promoter	(C57BL/6-tg(CAG-CagAHs),	and	when	limited	to	the	11	
gastric	mucosa	under	the	control	of	the	H+/K+	ATPase	β-subunit	promoter	(C57BL/6J-12	
tg(HK-CagAHs).	In	both	cases,	animals	developed	gastric	hypertrophy		by	12	weeks	of	13	
age,	 and	 over	 3	 years	 developed	 gastric	 dysplasia	 or	 occasionally	 gastric	14	
adenocarcinomas	(Ohnishi	et	al,	2008).		15	
Models	of	MALT	lymphoma		16	
Several	factors	make	Helicobacter	induced	MALT	lymphoma	challenging	to	model.	It	17	
is	 a	 rare	 outcome	 of	 H.	 pylori	 infection;	 it	 develops	 after	 a	 prolonged,	 complex	18	
interaction	among	the	bacteria,	host	epithelium	and	host	immune	system;	and	the	19	
commonest,	relatively	indolent	form	of	MALT	lymphoma	is	challenging	to	diagnose	20	
pathologically.	These	 issues	are	compounded	by	the	fact	that	natural	Helicobacter	21	
induced	MALT	 lymphomas	 have	 not	 been	 reported	 in	 commonly	 used	 laboratory	22	
species.	 Consequently,	 in	 some	 cases,	 only	 one	 research	 group	 	 has	 assessed	 the	23	
	31	
	
models	 described	 below,	 and	 substantial	 gaps	 remain	 in	 our	 knowledge	 of	 the	1	
mechanisms	involved	in	H.	pylori	induced	gastric	MALT	lymphoma	formation.		2	
Within	these	studies,	there	is	also	heterogeneity	in	the	criteria	used	to	report	MALT	3	
lymphoma	 formation.	 Most	 studies	 describe	 lymphoepithelial	 lesions	 as	 a	4	
pathognomic	event,	signifying	the	initiation	of	lymphomagenesis.	Other	studies	used	5	
evidence	 of	 monoclonal	 lymphoid	 aggregate	 formation	 as	 a	 surrogate	 for	 the	6	
development	of	MALT	lymphoma.	7	
Experimental	induction	of	MALT	lymphoma	by	H.	pylori	was	reported	in	a	single	study	8	
of	 conventionally	 housed	 Beagle	 dogs.	 This	 study	 described	 the	 formation	 of	9	
monoclonal	lymphoid	aggregates	in	the	gastric	mucosa	of	dogs	infected	with	H.	pylori	10	
strain	 SPM326s	 (CagA+)	 for	 6	months.	 This	 study	was	 not	 extended	 to	 later	 time	11	
points,	and	in	the	absence	of	epithelial	destruction,	or	evidence	of	genetic	instability,	12	
the	association	with	MALT	lymphoma	remains	somewhat	tenuous	(Rossi	et	al,	1999).	13	
In	addition,	the	pre-existing	gastric	Helicobacter	status	of	the	dogs	at	the	study	onset	14	
was	not		evaluated,	although	seropositivity	for	H.	pylori	was	excluded.	It	is	therefore	15	
not	 possible	 to	 conclude	 whether	 the	 observed	 phenotype	 was	 due	 to	H.	 pylori	16	
infection	in	isolation	or	to	a	synergy	between	H.	pylori	and	other	gastric	Helicobacter	17	
species.	18	
Several	NHPH	have	been	 reported	 to	 induce	either	MALT	 lymphoma	or	precursor	19	
lesions	in	laboratory	conditions.	Two	of	six	Mongolian	gerbils	infected	with	the	H.	suis	20	
strain,	HS5,	for	nine	months	developed	lymphoepithelial	lesions	(Flahou	et	al,	2010),	21	
whilst	outbred	Swiss,	and	inbred	Balb/c	and	C57BL/6,	mice	infected	with	a	variety	of	22	
NHPH	strains	developed	lymphoepithelial	lesions.		23	
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In	one	of	these	studies,	Enno	et	al	reported	that	25%	of	Balb/c	mice	colonized	with	1	
H.	felis	for	22-26	months	developed	advanced	lymphoepithelial	lesions,	and	a	further	2	
5%	had	early	lymphoepithelial	lesions	(Enno	et	al,	1995).	These	findings	have	since	3	
been	 independently	 replicated,	 and	 in	 the	 same	 study,	 a	 variety	 of	H.	 heilmannii	4	
strains	isolated	from	various	sources,	including	mandrill	monkeys	and	bobcats,	also	5	
induced	gastric	MALT	lymphomas	over	a	similar	timescale	(O'Rourke	et	al,	2004).		6	
A	 commonly	 used	 model	 of	 gastric	 carcinogenesis	 is	 the	 long	 term	 infection	 of	7	
C57BL/6	mice	with	H.	felis;	however,	these	mice	have	not	been	reported	to	develop	8	
gastric	 MALT	 lymphoma	 formation.	 They	 do,	 nevertheless,	 develop	 gastric	9	
lymphoepithelial	 lesions	and	 low-grade	MALT	 lymphomas	when	colonized	 for	one	10	
year	 with	 a	 candidatus	H.	 heilmanii	 isolated	 from	 the	 stomach	 of	 a	 cynomolgus	11	
monkey	 (Nakamura	 et	 al,	 2007).	More	 recently,	we	have	demonstrated	 that	 50%	12	
(3/6)	 of	 C57BL/6	 mice	 lacking	 the	 c-Rel	 NF-κB	 subunit	 developed	 early	13	
lymphoepithelial	 lesions	when	colonized	with	H.	 felis	 for	12	months	 (Burkitt	et	al,	14	
2013).	 This	 pathology	 has	 not	 previously	 been	 reported	 in	 the	 C57BL/6	 /	H.	 felis	15	
model.	This	suggests	that	signaling	through	the	c-Rel	NF-κB	subunit	could	influence	16	
the	regulation	of	gastric	MALT	lymphoma	formation.	17	
Overall,	 these	 data	 support	 the	 hypothesis	 that	 NHPH	 play	 a	 specific	 role	 in	 the	18	
development	of	MALT	lymphoma,	and	since	several	of	the	typical	H.	pylori	virulence	19	
factors	 are	 not	 expressed	 in	 these	Helicobacter	 species,	 this	 suggests	 that	 novel	20	
bacterial	factors	might	be	important	in	the	development	of	gastric	MALT	lymphoma.	21	
Future	work	in	this	field	needs	to	incorporate	models	of	genetic	instability,	in	addition	22	
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to	morphological	 criteria,	 to	 strengthen	 the	quality	 of	 data	 generated	 from	 these	1	
models.	2	
Ex-vivo	models	of	Helicobacter	infection	of	the	stomach	3	
To	date,	most	studies	investigating	the	mechanisms	that	underlie	H.	pylori	induced	4	
gastric	 pathology	 have	 relied	 on	 in-vivo	 models.	 Many	 of	 these	 models	 require	5	
prolonged	 exposure	 to	Helicobacter	 and	 use	 relatively	 large	 numbers	 of	 animals,	6	
raising	questions	of	animal	welfare	and	cost.	In	addition,	studying	the	interaction	of	7	
two	whole	organisms	(and	increasingly	the	rest	of	the	microbiome	to	which	H.	pylori	8	
contributes)	generates	hugely	complex	systems.	Some	studies	have	tried	to	address	9	
this	complexity	by	using	elegant	 transgenic	mouse	systems,	 for	example,	by	using	10	
tissue-specific	 transgenesis.	 However,	 these	 systems	 remain	 highly	 complex,	 and	11	
genetic	 manipulation	 	 can	 introduce	 further	 complexity,	 either	 through	 gene	12	
expression	in	a	suboptimal	location,	or	through	off-target	effects	of	the	drugs	used	13	
to	induce	genetic	recombination.		14	
There	is,	therefore,	a	need	for	better	in-vitro	or	ex-vivo	models	of	H.	pylori	associated	15	
pathology.	Over	the	past	six	years,	the	development	of	first	murine,	and	subsequently	16	
human,	three-dimensional,	primary	gastric	gland	cultures	called	gastric	organoids,	or	17	
‘gastroids’(see	Glossary,	Box	1)	has	opened	up	the	prospect	of	using	untransformed,	18	
gastric	tissue	in	culture	to	model	the	development	of	gastric	pathology	19	
Ex-vivo	gastric	mucosal	culture	models	20	
In	order	 to	 generate	 gastric	 glandular	units	 in	 culture,	 it	must	 first	 be	possible	 to	21	
isolate	primary	material	from	an	organism,	to	passage	this	material	in	vitro,	and	then	22	
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demonstrate	 its	 ability	 to	 differentiate	 into	 the	 different	 cell	 types	 of	 the	 gastric	1	
epithelium.	Ideally,	it	should	also	be	possible	to	store	the	cultures	in	the	laboratory	2	
and	reconstitute	them,	deriving	reproducible	results	 from	cultures	that	have	been	3	
stored	or	not	stored.	4	
Over	the	past	decade,	culture	systems	have	been	developed	that	fulfil	these	criteria.	5	
The	key	discovery	came	with	the	identification	of	Lgr5	as	a	marker	of	gastrointestinal	6	
stem	 cells	 (Barker	 et	 al,	 2010;	 Barker	 et	 al,	 2007).	 The	 identification	 of	 this	WNT	7	
signaling	family	member	as	a	key	marker	of	gastrointestinal	stem	cells	led	rapidly	to	8	
the	 development	 of	 primary	 culture	 systems	 that	 support	 these	 cells	 primarily	9	
through	the	optimization	of	WNT	signaling.	Since	these	discoveries,	several	groups	10	
have	 established	 gastric	 organoid	 systems	 using	 slightly	 different	 approaches	11	
(McCracken	et	al,	2014;	VanDussen	et	al,	2015),	as	described	below.	 	12	
Long-lived	gastric	epithelial	cultures	derived	from	primary	gastric	tissue		13	
The	generation	of	self-renewing	gastric	gland	cultures	was	first	described	by	Barker,	14	
using	methodology	developed	from	earlier	intestinal	organoid	models	(see	Glossary,	15	
Box	1)	established	by	the	same	group.	This	method	uses	Lgr5+	stem	cells	extracted	16	
from	the	gastric	antrum	of	mice	expressing	green	fluorescent	protein	(GFP)	under	the	17	
control	of	the	Lgr5	promoter	as	starting	material.	These	cells	are	supported	in	vitro	18	
in	a	3D	matrix	together	with	recombinant	growth	factors	that	together	recapitulate	19	
the	stem	cell	niche.	In	addition	to	activating	the	WNT	pathway,	transforming	growth	20	
factor-ß	(TGFß)	pathway	signaling	is	suppressed	and	gastrin-17	and	fibroblast	growth	21	
factor	 10	 (FGF10)	 are	 added	 as	 gastroid-specific	 growth	 factors.	During	 the	 initial	22	
phase	 of	 culture,	 the	 ROCK	 inhibitor	 Y-27632	 	 is	 added	 to	 the	 growth	 media	 to	23	
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prevent	anoikis.	This	methodology	established	Lgr5+	cells	as	gastric	antral	stem	cells;	1	
intriguingly,	an	effective	marker	for	the	gastric	corpus	stem	cell	remains	elusive.		2	
Subsequent	 protocols	 have	 established	 similar	 methods	 for	 the	 establishment	 of	3	
murine	 gastric	 organoid	 cultures	 from	 both	 antrum	 and	 corpus	 using	 non-4	
enzymatically	dissociated	gastric	glands	as	starting	material	(Mahe	et	al,	2013),	and	5	
for	organoids	based	on	gastric	tissue	samples	taken	at	the	time	of	gastric	resection	6	
(Bartfeld	 and	 Clevers,	 2015;	 Schlaermann	 et	 al,	 2016).	 These	 cultures	 generate	7	
spherical	cultures	that	maintain	a	3D	structure	in	culture	(Figure	5).	8	
	A	modification	of	this	protocol	uses	 	conditioned	media	from	the	L-WRN	cell	 line,	9	
which	secretes	human	Wnt3a,	Noggin	and	r-Spondin	3	(VanDussen	et	al,	2015).	This	10	
system	has	been	shown	to	allow	cultures	to	be	established	from	small	samples	taken	11	
during	 an	 endoscopic	 examination	 of	 the	 stomach,	 rather	 than	 requiring	 samples	12	
excised	 during	 surgery,	 and	 could	 be	more	 cost-effective	 due	 to	 the	 high	 cost	 of	13	
recombinant	growth	factors.	However,	the	use	of	this	cell	line	limits	the	control	that	14	
an	experimentalist	can	have	on	the	culture	system;	 in	particular,	gastric	organoids	15	
grown	using	this	method	are	exposed	to	particularly	high	levels	of	Wnt3a,	making	the	16	
cultures	 more	 proliferative	 and	 less	 likely	 to	 differentiate	 than	 gastric	 organoids	17	
established	using	recombinant	growth	factors.	18	
Most	reports	of	gastrointestinal	organoid	culture	systems	to	date	have	retained	the	19	
3D	 structure	 of	 organoids.	 However,	 an	 increasing	 number	 of	 studies	 use	 3D	20	
organoids	 as	 the	 source	 material	 to	 generate	 epithelial	 monolayers	 on	 collagen-21	
coated	 glass	 or	 plastics.	 This	 technique	 offers	 different	 opportunities	 for	22	
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quantification	and	observation	of	morphology,	which	in	some	cases	might	be	easier	1	
to	relate	back	to	more	established	2D	cancer	cell	cultures	(Schlaermann	et	al,	2016).	2	
Long-lived	gastric	epithelial	cultures	derived	from	induced	pluripotent	stem	cells	3	
Human	gastric	organoids	have	recently	been	generated	from	both	human	embryonic	4	
stem	cell	lines	and	induced	pluripotent	stem	cell	(iPSC)	lines	(McCracken	et	al,	2014).	5	
These	 stem	 cells	 were	 first	 differentiated	 into	 definitive	 endoderm	 before	 the	6	
induction	of	the	foregut	marker	SOX2,	by	exposure	to	WNT3A,	FGF4	and	Noggin.	They	7	
were	further	differentiated	into	“antral”	and	“corpus”	type	cultures	by	exposure	to	8	
retinoic	acid	and	subsequently	differentiated	into	mature	organoids	using	epidermal	9	
growth	factor	(EGF).		10	
Both	 antral-	 and	 corpus-type	 gastric	 organoids	 generated	 from	 such	 cultures	 are	11	
similar	 to	 their	 originating	 tissues,	 as	 shown	 by	 microarray	 and	 by	 gene	 set	12	
enrichment	 analyses	 (McCracken	 et	 al,	 2014).	 Morphologically,	 antral	 gland	 type	13	
organoids	also	contain	identifiable	epithelial	and	endocrine	cell	types.	Corpus	type	14	
organoids	 do	not	 possess	 parietal	 cells,	 however,	 other	markers	 of	 gastric	 corpus	15	
tissue,	including	expression	of	pepsinogens	and	ghrelin,	are	detectable.	16	
The	effect	of	Helicobacter	infection	on	cultured	gastric	organoids		17	
Several	groups	have	investigated	the	impact	of	H.	pylori	infection	on	gastric	organoid	18	
cultures.	The	most	reproduced	finding	is	that	epithelial	cell	proliferation	is	enhanced	19	
by	 direct	mucosal	 interaction	 with	H.	 pylori.	 This	 has	 been	 demonstrated	 by	 the	20	
microinjection	of	H.	pylori	 	 into	3D	fundic	gland	organoids	derived	from	both	mice	21	
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and	 humans	 (Bartfeld	 et	 al,	 2015;	 Bertaux-Skeirik	 et	 al,	 2015),	 and	 into	 human	1	
pluripotent	stem	cell-derived	gastric	organoids	(McCracken	et	al,	2014).	2	
H.	pylori	infection	also	induces	morphological	changes	in	2D	gastric-organoid-derived	3	
monolayers	grown	on	collagen-coated	glass	or	plastics,	with	epithelial	cells	taking	on	4	
a	 hummingbird	 morphology	 (Schlaermann	 et	 al,	 2016).	 This	 response	 was	 CagA	5	
dependent	 and	 appears	 to	 be	 analogous	 to	 the	 SHP2	 mediated	 hummingbird	6	
morphology	previously	described	in	gastric	cancer	cell	lines	(Higashi	et	al,	2002).	This	7	
change	 in	 morphology	 was	 associated	 with	 the	 activation	 of	 the	 classical	 NF-κB	8	
signaling	 pathway;	 this	 pathway	 is	 also	 implicated	 in	 the	 response	 of	 3D	 gastric	9	
organoids	 to	H.	pylori	microinjection	 (Schlaermann	 et	 al,	 2016;	 Schumacher	 et	 al,	10	
2015).	 In	 gastric	 cancer	 cell	 lines,	 this	 morphology	 is	 associated	 with	 a	 more	11	
aggressive,	 invasive	 phenotype	 (Chang	 et	 al,	 2016),	 and	 epithelial-mesenchymal	12	
transition	(Snider	et	al,	2008).	13	
Sigal	et	al.	have	established	an	organoid-formation	assay	in	which	they	quantified	the	14	
percentage	of	viable	organoids	formed	from	a	preparation	(Sigal	et	al,	2015).	Using	15	
this	assay,	they	verified	their	own	observation	that	the	antral	Lgr5+	stem	cell	zone	16	
expands	 in	 response	 to	 H.	 pylori	 infection.	 This	 provides	 a	 novel	 method	 for	17	
quantifying	the	abundance	of	antral	stem	cells.	18	
A	further	study	investigating	the	interactions	between	H.	pylori	and	human	gastric	19	
cells	in	the	context	of	organoids	has	demonstrated	that	H.	pylori	can	sense	nanomolar	20	
concentrations	of	urea,	and	use	this	as	a	chemoattractant.	This	study	made	use	of	21	
the	 observation	 that	whilst	most	 organoids	 form	with	 the	 luminal	 surface	 of	 the	22	
epithelium	facing	 inwards,	a	small	proportion	form	with	an	“inside-out”	structure.	23	
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This	 allowed	 the	 authors	 to	 observe	 epithelial	 and	 bacterial	 interactions,	 and	 in	1	
particular	the	adherence	of	H.	pylori	to	cell/cell	junctions	(Huang	et	al,	2015).		2	
Conclusions	3	
An	ever	more	diverse	array	of	laboratory	models	exists	to	explore	H.	pylori	induced	4	
pathology.	 The	 course	 of	 infection	 and	 plethora	 of	 outcomes	 in	 current	 in-vivo	5	
models	are	probably	too	complex	to	understand	fully	using	current	technology.	The	6	
new	generation	of	ex-vivo	models	offer	opportunities	to	be	more	systematic	in	our	7	
approach;	however,	at	present	they	also	risk	being	reductionist.	Over	time	we	need	8	
to	 develop	 ex-vivo	 systems	 that	 can	 be	 interrogated	 systematically,	 but	 which	9	
incorporate	key	elements	of	in-vivo	models,	including	host	epithelial,	mesenchymal	10	
and	immune	compartments,	and	both	Helicobacter	and	non-Helicobacter	microbiota.		11	
Currently	available	gastric	organoid	models	have	focused	largely	on	the	development	12	
of	organoids	from	healthy	animals	and	humans,	which	have	then		been	infected	with	13	
H.	 pylori.	 However,	 future	 studies	 will	 need	 to	 develop	 models	 that	 mimic	 the	14	
development	 of	 other	 gastric	 epithelial	 pathologies	 in	 culture.	 In	 particular,	 the	15	
development	of	3D	models	of	gastric	atrophy	and	metaplasia	will	allow	researchers	16	
to	 perform	 experiments	 to	 compare	 the	 effect	 of	 developing	 gastric	 epithelial	17	
pathology	in-vivo	and	ex-vivo.	Being	able	to	make	these	comparisons	will	allow	better	18	
mechanistic	studies	to	be	performed	in	the	relatively	simple	organoid	systems,	and	19	
verified	in	whole	animals.	This	will	allow	detailed	mechanistic	studies,	and	avoid	the	20	
pitfalls	of	a	reductionist	scientific	approach.	21	
The	results	of	these	studies	will	begin	to	provide	better	data	that	segregate	epithelial	22	
events	from	immune	and	mesenchymal	driven	changes	in	the	stomach.	Developing	23	
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these	models	presents	a	major	challenge	for	the	future	but,	 if	successful,	they	are	1	
likely	to	permit	the	design	and	evaluation	of	new	therapeutic	strategies	for	patients	2	
who	currently	have	no	meaningful	treatment	options.	 	3	
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Figure	Legends	3	
Figure	1:	Worldwide	prevalence	of	H.	pylori	infection	4	
A	map	showing	the	prevalence	of	H.	pylori	infection	in	different	parts	of	the	world.	5	
Note,	the	particularly	high	prevalence	in	sub-Saharan	Africa,	Latin	America	and	the	6	
Middle	 East.	 Australasia,	 Switzerland,	 and	 more	 generally	 North	 America	 and	7	
Western	Europe	have	the	lowest	incidence	of	H.	pylori	infection.	(Data	derived	from	8	
(Asfeldt	et	al,	2008;	Ben	Mansour	et	al,	2016;	Laszewicz	et	al,	2014;	Luzza	et	al,	2014;	9	
McDonald	et	al,	2015;	Peleteiro	et	al,	2014;	Saltanova,	2001;	Sanchez	Ceballos	et	al,	10	
2007;	van	Blankenstein	et	al,	2013)	11	
Figure	2:	The	anatomy	of	the	human	and	mouse	stomach	12	
A	schematic	of	the	anatomy	of	the	human	and	mouse	stomach	and	the	structure	of	13	
gastric	glands.	Two	types	of	columnar	mucosa	line	the	human	stomach:	the	antrum	14	
is	lined	with	antral	glands,	whilst	the	corpus	and	fundus	are	lined	with	deeper	oxyntic,	15	
or	 corpus	 glands	 (see	 Glossary,	 Box	 1).	 The	 murine	 stomach	 has	 areas	 that	 are	16	
analogous	to	the	human	stomach,	including	antral	and	corpus	glands,	and	it	also	has	17	
a	forestomach	lined	with	squamous	epithelium.	Stem	cells	that	reside	at	the	base	of	18	
the	gland	generate	the	antral	gland.	Following	asymmetric	cell	division	in	the	stem	19	
cell	zone,	daughter	cells	migrate	upwards	towards	the	gastric	lumen	and	differentiate	20	
into	mucous	neck,	surface	mucous	and	endocrine	cells.	 In	corpus	glands,	the	stem	21	
cell	niche	is	located	at	the	isthmus	of	the	gland.	Cells	migrate	upwards	from	the	stem	22	
cell	zone	and	differentiate	into	surface	mucous	cells.		Other	cells	migrate	down	the	23	
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gland	and	differentiate	into	acid-secreting	parietal	cells,	endocrine	cells,	or	zymogen-	1	
secreting	(see	Glossary,	Box	1)	chief	cells.	2	
	3	
Figure	3:	H.	pylori	infection	and	progression	to	gastric	cancer	4	
A	schematic	demonstrating	the	pathological	progression	of	H.	pylori	induced	gastric	5	
pre-neoplasia,	 and	 highlighting	 endogenous	 risk	 factors	 for	 progression	 towards	6	
gastric	cancer.	SPEM:	Spasmolytic	polypeptide	expressing	metaplasia.	7	
Figure	4:	Modeling	the	pathological	outcomes	of	Helicobacter	infection	8	
A	 schematic	 of	 the	 principal	 pathological	 outcomes	 of	 Helicobacter	 infection	 in	9	
humans,	annotated	with	details	of	the	best	characterized	 in-vivo	models	for	these	10	
conditions.	11	
Figure	5:	Gastric	organoid	culture	and	differentiation	12	
Diagrams	and	images	showing	the	maturation	of	gastric	organoids.	From	left	to	right,	13	
images	show	(A)	freshly	digested	gastric	corpus	glands	from	a	C57BL/6	mouse.	(B)		14	
Glands	24	hours	after	harvesting	that	have	formed	immature	organoids	and	have	a	15	
small	spherical	appearance.	 (C)	On	day	3	of	culture,	the	 immature	organoids	have	16	
expanded	and	 can	be	passaged.	 (D)	 Following	passage,	 the	organoids	 retain	 their	17	
spherical	appearance	and	continue	to	grow.	Images	from	authors’	own	laboratories.		18	
Scale	bars	250µm.	 	19	
	42	
	
Table	1.	Naturally	occurring	gastric	Helicobacter	infections	and	the	associated	host	1	
and	human	pathology.	2	
	3	
	 	
Helicobacter	
species	
Natural	host		 Natural	host	lesions	 Implicated	in	
human	gastric	
pathology	
H.	suis	 Pig,	macaque,	mandrill	
(Haesebrouck	et	al,	2009)		
In	pigs,	associated	
with	gastric	ulceration	
of	the	pars	esophagea	
(De	Bruyne	et	al,	
2012)		
Yes	
H.	felis	 Dog,	cat	(Priestnall	et	al,	2004)	
rabbit,	(Haesebrouck	et	al,	
2009),	cheetah	(Terio	et	al,	
2005),	mouse	
Associated	with	
gastritis	in	dogs	and	
cats	
Yes	
H.	bizzozeronii	 Dog,	cat	(Priestnall	et	al,	2004)	 Associated	with	
gastritis	in	dogs	and	
cats	
Yes	
H.	salomonis	 Dog,	cat,	rabbit	(Haesebrouck	
et	al,	2009)	
Associated	with	
gastritis	in	dogs	and	
cats	
Yes	
H.	heilmannii	 Dog,	cat,	wild	felidae,	non-
human	primates	
(Haesebrouck	et	al,	2009)	
In	cats,	hypothesized	
to	be	associated	with	
gastric	lymphoma	
(Bridgeford	et	al,	
2008a)	
Yes	
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H.	baculiformis	 Cat	(Baele	et	al,	2008)		 Associated	with	
gastritis		
No	
H.	cynogastricus	 Dog	(Van	den	Bulck	et	al,	
2006)		
Associated	with	
gastritis		
No	
H.	bovis	 Cattle	(De	Groote	et	al,	1999)		 No	known	pathology	 No	
H.	mustelae	 Ferret		 Gastritis,	gastric	pre-
malignant	lesions	and	
gastric	
adenocarcinoma	(Fox	
et	al,	1997)	and	gastric	
MALT	lymphoma	
(Erdman	et	al,	1997)	
	
No	
H.	aurati	 Syrian	hamster	(Patterson	et	
al,	2000)		
Gastric	
adenocarcinoma	with	
gastritis	and	intestinal	
metaplasia	
No	
H.	acinonychis	 Cheetah	(Eaton	et	al,	1993),	
tiger		
Gastric	ulcers	and	
erosions	in	tigers	
(Cattoli	et	al,	2000)	
No	
H.	cetorum	 Whales,	dolphins	(Harper	et	
al,	2002)		
Gastric	and	
oesophageal	
ulceration	in	whales	
and	dolphins	
No	
H.	pylori	 Humans	 Peptic	ulcer	disease,	
Gastric	
adenocarcinoma	and	
Yes	
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	 	1	
gastric	MALT	
lymphoma	
H.	pylori	 Rhesus	macaques	(Dubois	et	
al,	1994)	
Gastritis	 Yes	
H.	pylori	 Domestic	cat	(Canejo-Teixeira	
et	al,	2014)		
Gastritis	 Yes	
	45	
	
Box	1.	Glossary		1	
Achlorhydria:	Absence	of	gastric	acid.	In	a	patient	that	has	developed	gastric	atrophy	2	
the	acid	secreting	parietal	cells	are	lost,	and	hence	the	gastric	luminal	pH	is	elevated.	3	
This	 change	 in	microenvironment	 alters	 local	 hormone	 secretion,	 and	 potentially	4	
provides	a	niche	for	colonization	with	microbes	that	are	usually	unable	to	survive	the	5	
gastric	environment.	6	
Anthroponosis:	Infectious	disease	in	a	non-human	species	transmitted	from	humans.	7	
CagA:	Helicobacter	 pylori	 virulence	 factor.	 The	 secreted	 component	 of	 a	 type	 IV	8	
secretion	system,	the	cag	pathogenicity	island,	which	is	associated	with	more	severe	9	
gastric	pathology.	10	
Correa	Model:	A	model	of	gastric	carcinogenesis	first	proposed	by	Pelayo	Correa	in	11	
1975	(Correa	et	al,	1975),	describing	the	development	of	gastritis,	gastric	atrophy,	12	
gastric	 intestinal	 type	 metaplasia,	 dysplasia	 and	 finally	 gastric	 intestinal	 type	13	
adenocarcinoma.	14	
Dysplasia:	Replacement	of	normal	gastric	mucosa	with	structurally	abnormal	tissue	15	
with	potentially	abnormal	proliferation,	disordered	arrangement	of	cells	within	the	16	
tissue,	and	structurally	abnormal	cells.	17	
Gastrin:	A	hormone	produced	in	the	stomach	that	stimulates	the	production	of	acid	18	
by	parietal	cells,	mainly	through	its	interaction	with	histamine	secreting	ECL	cells.	In	19	
addition	to	its	role	in	stimulating	gastric	acid	secretion	gastrin	is	also	a	growth		factor,	20	
which	stimulates	gastric	epithelial	cell	proliferation.	21	
Gastritis:	Inflammation	of	the	epithelial	lining	of	the	stomach.	22	
Gastric	organoid/gastroid:	An	organoid	generated	from	gastric	epithelial	stem	cells.	23	
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Hypergastrinemia:		An	elevated	level	of	the	hormone	gastrin	in	the	bloodstream.	This	1	
is	 observed	particularly	 in	 the	 context	of	 gastric	 pre-neoplasia,	where	 the	 growth	2	
factor	function	of	gastrin	is	thought	to	promote	increased	epithelial	cell	proliferation.	3	
Metaplasia:	Replacement	of	one	differentiated	epithelial	tissue	by	another,	which	is	4	
abnormal	for	that	anatomical	site.	5	
Microaerophilic:	 A	 term	 that	 describes	 a	 bacterium	 adapted	 to	 survive	 in	 an	6	
environment	with	reduced	partial	oxygen	pressure.	7	
Organoid:	 A	 primary	 epithelial	 cell	 culture	 that	 contains	 healthy,	 proliferating	8	
epithelial	 stem	 cells,	 which	 can	 be	 expanded	 and	 passaged	 multiple	 times,	 and	9	
generates	daughter	cells	representative	of	all	lineages	generated	by	the	stem	cell	in-10	
vivo.		11	
Oxyntic	gland:	An	acid-secreting	gland	that	consists	of	an	epithelial	monolayer	with	12	
a	 proliferative	 stem	 cell	 zone	 towards	 the	 upper	 third	 of	 the	 gland.	 Asymmetric	13	
proliferation	in	this	region	generates	daughter	cells	that	migrate	both	up	and	down	14	
the	 gland	 and	 	 differentiate	 into	 mucus	 neck	 cells,	 parietal	 cells,	 chief	 cells	 and	15	
enteroendocrine	cells.	16	
Pars	 esophagea:	 A	 small	 area	 of	 non-glandular	 squamous	 mucosa	 near	 the	17	
esophageal	opening	present	 in	the	stomachs	of	some	animals	that	 is	analogous	to	18	
the	esophageal	mucosa	in	humans.	19	
Polymorphonuclear	leukocyte	infiltration:	The	recruitment	of	multi-lobulated	white	20	
blood	cells	(including	neutrophils,	basophils	and	eosinophils)	into	an	epithelial	tissue.	21	
Indicative	of	active	inflammation	in	the	tissue.		22	
Zoonosis:	Infectious	disease	in	a	human	transmitted	from	an	animal	host.	23	
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Zymogen:	The	inactive	form	of	a	digestive	enzyme,	for	example	pepsinogen,		which	1	
is	 an	 inactive	 form	 of	 the	 proteolytic	 enzyme,	 pepsin.	 Pepsinogen	 is	 activated	 by	2	
gastric	acid	secreted	by	parietal	cells.	 	3	
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